The Impact of Cell Density and Mutations in a Model of Multidrug Resistance in Solid Tumors

In this paper we develop a mathematical framework for describing multidrug resistance in cancer. To reflect the complexity of the underlying interplay between cancer cells and the therapeutic agent, we assume that the resistance level is a continuous parameter. Our model is written as a system of integro-differential equations that are parameterized by the resistance level. This model incorporates the cell density and mutation dependence. Analysis and simulations of the model demonstrate how the dynamics evolves to a selection of one or more traits corresponding to different levels of resistance. The emerging limit distribution with nonzero variance is the desirable modeling outcome as it represents tumor heterogeneity.

[1]  Laird Ak.  DYNAMICS OF TUMOR GROWTH. , 1964 .

[2]  A. K. Laird.  Dynamics of Tumour Growth , 1964, British Journal of Cancer.

[3]  L. Norton,et al.  Tumor size, sensitivity to therapy, and design of treatment schedules. , 1977, Cancer treatment reports.

[4]  L. Norton,et al.  Growth curve of an experimental solid tumor following radiotherapy. , 1977, Journal of the National Cancer Institute.

[5]  Goldie Jh,et al.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979 .

[6]  J H Goldie,et al.  A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. , 1979, Cancer treatment reports.

[7]  Goldie Jh,et al.  Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982 .

[8]  J H Goldie,et al.  Rationale for the use of alternating non-cross-resistant chemotherapy. , 1982, Cancer treatment reports.

[9]  J. Goldie,et al.  Quantitative model for multiple levels of drug resistance in clinical tumors. , 1983, Cancer treatment reports.

[10]  J. Goldie,et al.  A model for the resistance of tumor cells to cancer chemotherapeutic agents , 1983 .

[11]  Goldie Jh,et al.  Role of mathematical modeling in protocol formulation in cancer chemotherapy. , 1985 .

[12]  L Corcoran,et al.  Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c‐myc oncogene. , 1985, The EMBO journal.

[13]  L. Norton,et al.  The Norton-Simon hypothesis revisited. , 1986, Cancer treatment reports.

[14]  J H Goldie,et al.  A stochastic model for the origin and treatment of tumors containing drug-resistant cells. , 1986, Bulletin of mathematical biology.

[15]  R Rosen,et al.  "Role of mathematical modeling in protocol formulation in cancer chemotherapy". , 1986, Cancer treatment reports.

[16]  S Gallivan,et al.  A mathematical model of the development of drug resistance to cancer chemotherapy. , 1987, European journal of cancer & clinical oncology.

[17]  M Kimmel,et al.  Mathematical models of gene amplification with applications to cellular drug resistance and tumorigenicity. , 1990, Genetics.

[18]  Z. Agur,et al.  The dynamics of gene amplification described as a multitype compartmental model and as a branching process. , 1991, Mathematical biosciences.

[19]  S. Michelson,et al.  A mathematical model of the P-glycoprotein pump as a mediator of multidrug resistance. , 1992, Bulletin of mathematical biology.

[20]  O. Bogler,et al.  A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. , 1996, Cancer research.

[21]  K. Miyazono,et al.  Cell Density-dependent Apoptosis in HL-60 Cells, Which Is Mediated by an Unknown Soluble Factor, Is Inhibited By Transforming Growth Factor β1 and Overexpression of Bcl-2* , 1997, The Journal of Biological Chemistry.

[22]  Nicola Bellomo,et al.  Nonlinear models and problems in applied sciences from differential quadrature to generalized collocation methods , 1997 .

[23]  J. Panetta,et al.  A mathematical model of drug resistance: heterogeneous tumors. , 1998, Mathematical biosciences.

[24]  G. Farrell,et al.  The effects of cell density, attachment substratum and dexamethasone on spontaneous apoptosis of rat hepatocytes in primary culture , 1999, In Vitro Cellular & Developmental Biology - Animal.

[25]  G. Webb,et al.  Mutation, selection, and recombination in a model of phenotype evolution , 1999 .

[26]  H M Byrne,et al.  A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy. , 2000, Mathematical biosciences.

[27]  À. Calsina,et al.  A model for the adaptive dynamics of the maturation age , 2000 .

[28]  Sophie Lelièvre,et al.  beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. , 2002, Cancer cell.

[29]  Urszula Foryś,et al.  Logistic Equations in Tumour Growth Modelling , 2003 .

[30]  Baofeng Yang,et al.  Opposite Cell Density-Dependence between Spontaneous and Oxidative Stress-Induced Apoptosis in Mouse Fibroblast L-Cells , 2003, Cellular Physiology and Biochemistry.

[31]  John Carl Panetta,et al.  Optimal Control Applied to Competing Chemotherapeutic Cell-Kill Strategies , 2003, SIAM J. Appl. Math..

[32]  Sílvia Cuadrado,et al.  Small mutation rate and evolutionarily stable strategies in infinite dimensional adaptive dynamics , 2004, Journal of mathematical biology.

[33]  Nastaran Zahir,et al.  Death in the third dimension: apoptosis regulation and tissue architecture. , 2004, Current opinion in genetics & development.

[34]  Urszula Ledzewicz,et al.  Drug resistance in cancer chemotherapy as an optimal control problem , 2005 .

[35]  Dominik Wodarz,et al.  Drug resistance in cancer: principles of emergence and prevention. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Perthame,et al.  The dynamics of adaptation: an illuminating example and a Hamilton-Jacobi approach. , 2005, Theoretical population biology.

[37]  N. Komarova,et al.  Stochastic modeling of drug resistance in cancer. , 2006, Journal of theoretical biology.

[38]  I. Tannock,et al.  The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.

[39]  B. Perthame.  Transport Equations in Biology , 2006 .

[40]  R. Ferrière,et al.  Unifying evolutionary dynamics: from individual stochastic processes to macroscopic models. , 2006, Theoretical population biology.

[41]  L. Sander,et al.  Dynamics and pattern formation in invasive tumor growth. , 2005, Physical review letters.

[42]  G. Barles,et al.  Dirac concentrations in Lotka-Volterra parabolic PDEs , 2007, 0708.3720.

[43]  Michael Berens,et al.  A mathematical model of glioblastoma tumor spheroid invasion in a three-dimensional in vitro experiment. , 2007, Biophysical journal.

[44]  S. Mischler,et al.  On selection dynamics for continuous structured populations , 2008 .

[45]  Christopher P Austin,et al.  A dual-fluorescence high-throughput cell line system for probing multidrug resistance. , 2009, Assay and drug development technologies.

[46]  Jean-Pierre Gillet,et al.  Mechanisms of multidrug resistance in cancer. , 2010, Methods in molecular biology.

[47]  D. Levy,et al.  An elementary approach to modeling drug resistance in cancer. , 2010, Mathematical biosciences and engineering : MBE.

[48]  B. Perthame,et al.  Dirac Mass Dynamics in Multidimensional Nonlocal Parabolic Equations , 2010, 1011.1768.

[49]  L. Liotta,et al.  Mechanism of Cell Adaptation: When and How Do Cancer Cells Develop Chemoresistance? , 2011, Cancer journal.

[50]  B. Perthame,et al.  Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies , 2012, 1207.0923.

[51]  Doron Levy,et al.  The dynamics of drug resistance: a mathematical perspective. , 2012, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[52]  Martin A Nowak,et al.  Dynamics of targeted cancer therapy. , 2012, Trends in molecular medicine.

[53]  R. Minchin,et al.  Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives , 2012, EMBO molecular medicine.

[54]  M. Textor,et al.  Controlled Breast Cancer Microarrays for the Deconvolution of Cellular Multilayering and Density Effects upon Drug Responses , 2012, PloS one.

[55]  Kornelia Polyak,et al.  Cancer Cell Phenotypes, in Fifty Shades of Grey , 2013, Science.

[56]  M. Gottesman,et al.  The Role of Cell Density and Intratumoral Heterogeneity in Multidrug Resistance , 2013 .

[57]  Andrew M. K. Brown,et al.  Variable Clonal Repopulation Dynamics Influence Chemotherapy Response in Colorectal Cancer , 2013, Science.

[58]  Doron Levy,et al.  Simplifying the complexity of resistance heterogeneity in metastasis. , 2014, Trends in molecular medicine.

[59]  Kornelia Polyak,et al.  Cancer Cell Phenotypes, in Fifty Shades of Grey , 2013, Science.